Developing Breakthrough Treatments for Invasive Lobular Carcinoma
Oct 25, 2022•5 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Invasive Lobular Carcinoma (ILC) is the second most common subtype of breast cancer, with 2,400 new cases each year in Australia.
Patients with ILC may have a poorer outcome over time and the cancer has a tendency to metastasize to atypical sites such as the gastrointestinal tract, gynaecological organs or orbit (eye).
We spoke with Dr Sokolova about her research project, which will examine a new treatment approach directed at ILC.
For the best experience, listen in Metacast app for iOS or Android